University of Pennsylvania Medical Center Guidelines for Antibiotic Use
| Endocarditis Prophylaxis is Recommended for People Only with the Following Conditions |
Prosthetic cardiac valves (including bioprosthetic and homograft valves) Previous bacterial endocarditis Unrepaired cyanotic congenital heart disease (CHD), including palliative shunts and conduits Completely repaired congenital heart defect with prosthetic material or device, whether placed by surgery or by catheter, but only during the 1st six months after the procedure Repaired CHD with residual defects at the site or adjacent to the site of a prosthetic patch or prosthetic device Cardiac transplantation recipients who develop cardiac valvulopathy
|
|
||||||||||||
| For patients with established GU or other intraabdominal infections, the guidelines suggest that anti-enterococcal therapy may be indicated, if the patients meet the criteria for requiring prophylaxis - call an infectious diseases consultant for questions on this point. |
1Recommendations of the American Heart Association (Circulation 2007;115 - May 8th issue); refer to article for a complete discussion about the topic
2This table is not meant to be all-inclusive. Please read the complete text of the guidelines for details.
| Situation | Drug | Dosage Regimen- all single dose only, within 30 to 60 minutes prior to procedure |
| Oral therapy | amoxicillin | 2gm PO |
| Unable to take oral medications | ampicillin | 2gm IM or IV |
| OR cefazolin | 1 gm IM or IV | |
| Allergic to penicillins or ampicillin- oral dosing | cephalexin2 OR | 2gm PO |
| clindamycin OR | 600mg PO | |
| azithromycin or clarithromycin | 500mg PO | |
| Allergic to penicillin or ampicillin and unable to take oral medications | cefazolin2 OR | 1gm IM or IV |
| clindamycin | 600mg IV | |
| Surgery on infected soft tissues | cefazolin OR vancomycin, depending on antimicrobial susceptibility | see above for dosage |
| Cystoscopy when UTI eradication not possible | anti-enterococcal therapy (amoxicillin or vancomycin), depending on antimicrobial susceptibility, if available. If not available, consult with infectious diseases. | see above for dosage |
| Recent prior or concurrent antimicrobial therapy | consult with infectious diseases, see full text of AHA guidelines |
1Modified from recommendations of the American Heart Association (Circulation 2007;115 - May 8th issue); refer to article for a complete discussion about the topic. Ceftriaxone usage omitted from UPHS recommendations.
2Cephalosporins should not be used in individuals with immediate-type hypersensitivity reactions (urticaria, angioedema or anaphylaxis to penicillins or ampicillin)
Written by P. Edelstein, 5/23/07